US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Therapeutics

13.66

-0.3500-2.50%

Post-market: 13.750.0900+0.66%18:34 EST

Volume:495.36K

Turnover:6.87M

Market Cap:427.42M

PE:-6.48

High:14.35

Open:14.13

Low:13.58

Close:14.01

52wk High:50.40

52wk Low:13.58

Shares:31.29M

Float Shares:15.69M

Volume Ratio:0.55

T/O Rate:3.16%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.1087

EPS(LYR):-2.3387

ROE:-28.78%

ROA:-19.52%

PB:2.20

PE(LYR):-5.84

Loading ...

Overview Company News Filings

Amplia Therapeutics Opens Two Sites for Pancreatic Cancer Trial Enrollment; Shares Rise 4%

MT Newswires Live

Neural Therapeutics’ Hanf.com Stake Delivers 58% Revenue Surge and Positive Operating Income

Wedbush Cuts Price Target on Aprea Therapeutics to $7 From $11, Keeps Outperform Rating

MT Newswires Live

Defence Therapeutics Refines Accum ADC Strategy With New Scientific Advisory Board

Rapid Dose Therapeutics Enters Brazil’s Medical Cannabis Market With QuickStrip Launch

Cardiol Therapeutics’ ARCHER Phase II Myocarditis Data Published in ESC Heart Failure

Sangamo Therapeutics Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Why Is Quince Therapeutics Stock Soaring Tuesday?

Agomab Therapeutics Closes $200 Million IPO

MT Newswires Live

Marker Therapeutics Sets Date for 2026 Annual Meeting

Lineage Cell Therapeutics Is Maintained at Buy by D. Boral Capital

Context Therapeutics to Participate in Upcoming Investor Conferences

Oruka Therapeutics to Participate in Multiple Upcoming Conferences

Vistagen Therapeutics Securities Litigation: When Clinical Optimism Meets Disclosure Duty

Stifel Nicolaus Reaffirms Their Hold Rating on HLS Therapeutics Inc (HLS)

Shield Therapeutics Wins Extra U.S. FDA Exclusivity for ACCRUFeR Pediatric Use

Arovella Therapeutics Announces Departure of Director Gary Phillips

PYC Therapeutics Opens Retail Entitlement Offer to Fund RNA Therapy Pipeline

Arovella Therapeutics Interim Chair Retires; Shares Up 4%

MT Newswires Live

Assessing CARsgen Therapeutics Holdings’ Valuation After 2025 Earnings Guidance Points To Smaller Net Loss

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/LENZ/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LENZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","market":"US","secType":"STK","nameCN":"Therapeutics","latestPrice":13.66,"timestamp":1770757200000,"preClose":14.01,"halted":0,"volume":495362,"hourTrading":{"tag":"盘后","latestPrice":13.75,"preClose":13.66,"latestTime":"18:34 EST","volume":8851,"amount":121024.1,"timestamp":1770766448884,"change":0.09,"changeRate":0.006589,"amplitude":0.007321},"delay":0,"changeRate":-0.02498215560314059,"floatShares":15692500,"shares":31289969,"eps":-2.10871,"marketStatus":"Closed","change":-0.35,"latestTime":"02-10 16:00:00 EST","open":14.13,"high":14.35,"low":13.58,"amount":6871210.389218,"amplitude":0.054961,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.10871,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770800400000},"marketStatusCode":5,"adr":0,"listingDate":1624593600000,"exchange":"NASDAQ","adjPreClose":14.01,"preHourTrading":{"tag":"盘前","latestPrice":14.3,"preClose":14.01,"latestTime":"08:00 EST","volume":1255,"amount":17946.5,"timestamp":1770728407728,"change":0.29,"changeRate":0.0207,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":13.75,"preClose":13.66,"latestTime":"18:34 EST","volume":8851,"amount":121024.1,"timestamp":1770766448884,"change":0.09,"changeRate":0.006589,"amplitude":0.007321},"volumeRatio":0.551954,"impliedVol":1.0143,"impliedVolPercentile":0.7725},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","floatShares":15692500,"roa":"-19.52%","roe":"-28.78%","lyrEps":-2.338654,"volumeRatio":0.551954,"shares":31289969,"dividePrice":0,"high":14.35,"amplitude":0.054961,"preClose":14.01,"low":13.58,"week52Low":13.58,"pbRate":"2.20","psRate":"24.42","week52High":50.4,"institutionHeld":0,"latestPrice":13.66,"eps":-2.10871,"divideRate":0,"volume":495362,"delay":0,"ttmEps":-2.10871,"open":14.13,"prevYearClose":16,"prevWeekClose":14.22,"prevMonthClose":15.82,"prevQuarterClose":16,"fiveDayClose":15.53,"twentyDayClose":15.57,"sixtyDayClose":25.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LENZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-01-07","symbol":"LENZ","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1767762000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-11-05","symbol":"LENZ","fiscalQuarterEnding":"2025/09","expectedEps":-0.67,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"pre","actualEps":-0.59},{"market":"US","date":"2025-07-30","symbol":"LENZ","fiscalQuarterEnding":"2025/06","expectedEps":-0.58,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1753848000000,"reportTimeType":"pre","actualEps":-0.53},{"market":"US","date":"2024-05-08","symbol":"LENZ","fiscalQuarterEnding":"2024/03","expectedEps":-0.84,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"pre","actualEps":-3.53},{"market":"US","date":"2024-03-22","symbol":"LENZ","defaultRemindTime":1711114200000,"type":"split","dateTimestamp":1711080000000,"forFactor":7,"toFactor":1,"ratio":7}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LENZ\",market:\"US\",,,undefined,":[{"executeDate":"2024-03-22","recordDate":"2024-03-18","paymentDate":"2024-03-21","value":1.03,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LENZ\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5714,"buy":0.4286,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5714,"analysts":7,"updateTime":1742360400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LENZ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LENZ","date":"2026-02-09","current":-6.544285,"percent":0.855556,"low":-26.69966,"twenty":-17.191911,"median":-11.545952,"eighty":-8.358948,"high":-5.069183,"avg":-12.916349,"sd":5.106936,"marketCap":444943359},"quantilePoints":[{"date":"2024-03-28","current":-7.959158,"twenty":-7.219077,"median":-6.108955,"eighty":-6.016992,"marketCap":556886354},{"date":"2024-04-05","current":-7.492045,"twenty":-7.873034,"median":-7.667213,"eighty":-6.662191,"marketCap":524203432},{"date":"2024-04-12","current":-7.929963,"twenty":-7.855517,"median":-7.667213,"eighty":-7.432197,"marketCap":554843672},{"date":"2024-04-19","current":-6.382653,"twenty":-7.855517,"median":-7.488396,"eighty":-6.783348,"marketCap":446581492},{"date":"2024-04-26","current":-5.638193,"twenty":-7.716113,"median":-7.451903,"eighty":-5.889996,"marketCap":394493084},{"date":"2024-05-03","current":-5.988527,"twenty":-7.671592,"median":-6.864363,"eighty":-5.803142,"marketCap":419005276},{"date":"2024-05-10","current":-5.317808,"twenty":-7.667213,"median":-6.108955,"eighty":-5.803142,"marketCap":393230653},{"date":"2024-05-17","current":-5.708011,"twenty":-7.597146,"median":-6.0013,"eighty":-5.749862,"marketCap":422084590},{"date":"2024-05-24","current":-5.428308,"twenty":-7.489126,"median":-6.006774,"eighty":-5.719496,"marketCap":401401679},{"date":"2024-05-31","current":-5.355793,"twenty":-7.479638,"median":-5.988527,"eighty":-5.522773,"marketCap":396039443},{"date":"2024-06-07","current":-5.193496,"twenty":-7.457742,"median":-5.904593,"eighty":-5.428999,"marketCap":384038248},{"date":"2024-06-14","current":-6.433167,"twenty":-7.451903,"median":-5.930138,"eighty":-5.428308,"marketCap":475706952},{"date":"2024-06-21","current":-6.236339,"twenty":-7.425628,"median":-5.992177,"eighty":-5.43107,"marketCap":461152311},{"date":"2024-06-28","current":-6.150011,"twenty":-7.389135,"median":-6.0013,"eighty":-5.439358,"marketCap":454768696},{"date":"2024-07-05","current":-6.098214,"twenty":-7.269437,"median":-6.014073,"eighty":-5.469746,"marketCap":450938528},{"date":"2024-07-12","current":-6.771573,"twenty":-6.771573,"median":-6.098214,"eighty":-5.493918,"marketCap":500730721},{"date":"2024-07-15","current":-7.261916,"twenty":-7.163847,"median":-6.103393,"eighty":-5.509112,"marketCap":536989651},{"date":"2024-08-02","current":-8.498134,"twenty":-7.266429,"median":-6.108573,"eighty":-5.524305,"marketCap":628403011},{"date":"2024-08-09","current":-8.328931,"twenty":-7.474529,"median":-6.146558,"eighty":-5.597209,"marketCap":615891126},{"date":"2024-08-16","current":-8.944708,"twenty":-7.671592,"median":-6.236339,"eighty":-5.641258,"marketCap":621424629},{"date":"2024-08-23","current":-8.79431,"twenty":-7.94748,"median":-6.352018,"eighty":-5.670717,"marketCap":610975896},{"date":"2024-08-30","current":-8.746816,"twenty":-8.006409,"median":-6.382653,"eighty":-5.719496,"marketCap":607676296},{"date":"2024-09-06","current":-9.451311,"twenty":-8.199004,"median":-6.419354,"eighty":-5.743293,"marketCap":656620360},{"date":"2024-09-13","current":-8.17293,"twenty":-8.352945,"median":-6.434893,"eighty":-5.773217,"marketCap":567806132},{"date":"2024-09-20","current":-8.7389,"twenty":-8.507104,"median":-6.459289,"eighty":-5.788545,"marketCap":607126363},{"date":"2024-09-27","current":-8.806184,"twenty":-8.638371,"median":-6.616182,"eighty":-5.792924,"marketCap":611800796},{"date":"2024-10-04","current":-8.897214,"twenty":-8.745233,"median":-7.269437,"eighty":-5.800953,"marketCap":618125029},{"date":"2024-10-11","current":-9.340491,"twenty":-8.850511,"median":-7.455552,"eighty":-5.81701,"marketCap":648921294},{"date":"2024-10-18","current":-10.417023,"twenty":-8.905129,"median":-7.492045,"eighty":-5.857882,"marketCap":723712222},{"date":"2024-10-25","current":-9.902504,"twenty":-9.0017,"median":-7.670862,"eighty":-5.904593,"marketCap":687966558},{"date":"2024-10-31","current":-10.939457,"twenty":-9.257377,"median":-7.718702,"eighty":-5.904593,"marketCap":760007820},{"date":"2024-11-08","current":-14.709443,"twenty":-9.419648,"median":-7.959158,"eighty":-5.955683,"marketCap":894466512},{"date":"2024-11-15","current":-15.344855,"twenty":-9.514636,"median":-8.00261,"eighty":-5.970448,"marketCap":933105265},{"date":"2024-11-22","current":-15.521232,"twenty":-9.76398,"median":-8.132103,"eighty":-5.988527,"marketCap":943830613},{"date":"2024-11-29","current":-16.100113,"twenty":-9.924668,"median":-8.17293,"eighty":-5.994366,"marketCap":979031755},{"date":"2024-12-06","current":-16.33076,"twenty":-10.388526,"median":-8.285117,"eighty":-6.004584,"marketCap":993057210},{"date":"2024-12-13","current":-13.920266,"twenty":-10.815972,"median":-8.351032,"eighty":-6.018452,"marketCap":846477455},{"date":"2024-12-20","current":-13.694141,"twenty":-11.182468,"median":-8.50374,"eighty":-6.082845,"marketCap":832727009},{"date":"2024-12-27","current":-14.476534,"twenty":-12.093039,"median":-8.531114,"eighty":-6.098214,"marketCap":880303552},{"date":"2025-01-03","current":-12.794163,"twenty":-13.449021,"median":-8.618187,"eighty":-6.102358,"marketCap":778000234},{"date":"2025-01-10","current":-11.912274,"twenty":-13.190334,"median":-8.707238,"eighty":-6.108649,"marketCap":724373495},{"date":"2025-01-17","current":-10.130408,"twenty":-13.019383,"median":-8.746816,"eighty":-6.115785,"marketCap":616019980},{"date":"2025-01-24","current":-11.197719,"twenty":-12.871045,"median":-8.79431,"eighty":-6.143105,"marketCap":680922085},{"date":"2025-01-31","current":-11.523339,"twenty":-12.794163,"median":-8.877425,"eighty":-6.150011,"marketCap":700722728},{"date":"2025-02-07","current":-12.070562,"twenty":-12.328345,"median":-8.905129,"eighty":-6.232886,"marketCap":733998807},{"date":"2025-02-14","current":-11.432889,"twenty":-12.292165,"median":-8.964497,"eighty":-6.236339,"marketCap":695222549},{"date":"2025-02-21","current":-11.279124,"twenty":-12.151063,"median":-8.998138,"eighty":-6.308164,"marketCap":685872246},{"date":"2025-02-28","current":-9.62841,"twenty":-12.079607,"median":-9.059485,"eighty":-6.342695,"marketCap":585493990},{"date":"2025-03-07","current":-10.297741,"twenty":-11.943932,"median":-9.320702,"eighty":-6.355126,"marketCap":626195310},{"date":"2025-03-14","current":-11.193196,"twenty":-11.879712,"median":-9.419648,"eighty":-6.365485,"marketCap":680647077},{"date":"2025-03-21","current":-14.554795,"twenty":-11.943932,"median":-9.482973,"eighty":-6.379634,"marketCap":724377586},{"date":"2025-03-28","current":-14.68208,"twenty":-12.421509,"median":-9.574004,"eighty":-6.398202,"marketCap":730712447},{"date":"2025-04-04","current":-12.728528,"twenty":-13.089934,"median":-9.668992,"eighty":-6.415901,"marketCap":633486102},{"date":"2025-04-11","current":-10.2603,"twenty":-12.90813,"median":-9.741473,"eighty":-6.42488,"marketCap":510644883},{"date":"2025-04-17","current":-12.761733,"twenty":-12.945214,"median":-9.779811,"eighty":-6.430405,"marketCap":635138674},{"date":"2025-04-25","current":-15.833323,"twenty":-13.271407,"median":-9.84549,"eighty":-6.435239,"marketCap":788008663},{"date":"2025-05-02","current":-15.982746,"twenty":-13.932929,"median":-9.940463,"eighty":-6.440764,"marketCap":795445305},{"date":"2025-05-09","current":-15.25222,"twenty":-14.136351,"median":-10.102399,"eighty":-6.452984,"marketCap":728141003},{"date":"2025-05-16","current":-16.118891,"twenty":-14.245886,"median":-10.138549,"eighty":-6.460191,"marketCap":769515850},{"date":"2025-05-23","current":-16.637714,"twenty":-14.356129,"median":-10.19625,"eighty":-6.460792,"marketCap":794284465},{"date":"2025-05-30","current":-17.410053,"twenty":-14.523491,"median":-10.236057,"eighty":-6.585104,"marketCap":831155927},{"date":"2025-06-06","current":-17.864023,"twenty":-14.65894,"median":-10.342966,"eighty":-6.96771,"marketCap":852828466},{"date":"2025-06-13","current":-17.439532,"twenty":-14.747436,"median":-10.384797,"eighty":-7.264924,"marketCap":832563235},{"date":"2025-06-20","current":-17.704839,"twenty":-14.88454,"median":-10.454615,"eighty":-7.299361,"marketCap":845229004},{"date":"2025-06-27","current":-17.752005,"twenty":-15.005667,"median":-10.623361,"eighty":-7.425628,"marketCap":847480696},{"date":"2025-07-03","current":-19.178768,"twenty":-15.33581,"median":-10.694071,"eighty":-7.451903,"marketCap":915594389},{"date":"2025-07-11","current":-20.198727,"twenty":-15.529319,"median":-10.766979,"eighty":-7.459202,"marketCap":964287236},{"date":"2025-07-18","current":-20.381494,"twenty":-15.833323,"median":-10.791578,"eighty":-7.484747,"marketCap":973012543},{"date":"2025-07-25","current":-19.691695,"twenty":-16.100113,"median":-11.044571,"eighty":-7.492045,"marketCap":940081543},{"date":"2025-08-01","current":-16.20487,"twenty":-16.158905,"median":-11.077981,"eighty":-7.667213,"marketCap":849102797},{"date":"2025-08-08","current":-17.484059,"twenty":-16.20487,"median":-11.141188,"eighty":-7.667213,"marketCap":916129723},{"date":"2025-08-15","current":-22.268769,"twenty":-16.33076,"median":-11.193196,"eighty":-7.674511,"marketCap":1166838947},{"date":"2025-08-22","current":-21.691773,"twenty":-16.434778,"median":-11.220775,"eighty":-7.693556,"marketCap":1136605525},{"date":"2025-08-29","current":-20.793619,"twenty":-16.611183,"median":-11.233899,"eighty":-7.743848,"marketCap":1089544067},{"date":"2025-09-05","current":-21.729877,"twenty":-16.749673,"median":-11.252126,"eighty":-7.89274,"marketCap":1138602072},{"date":"2025-09-12","current":-22.214335,"twenty":-16.928962,"median":-11.290275,"eighty":-7.953319,"marketCap":1163986737},{"date":"2025-09-19","current":-22.693351,"twenty":-17.073997,"median":-11.339198,"eighty":-7.982513,"marketCap":1189086182},{"date":"2025-09-26","current":-21.789753,"twenty":-17.210778,"median":-11.419321,"eighty":-7.998378,"marketCap":1141739502},{"date":"2025-10-03","current":-26.302295,"twenty":-17.347559,"median":-11.473592,"eighty":-8.003646,"marketCap":1378187678},{"date":"2025-10-10","current":-25.175521,"twenty":-17.497557,"median":-11.534645,"eighty":-8.0071,"marketCap":1319146940},{"date":"2025-10-17","current":-22.018374,"twenty":-17.690689,"median":-11.749464,"eighty":-8.107241,"marketCap":1153718783},{"date":"2025-10-24","current":-16.034033,"twenty":-17.707197,"median":-11.991418,"eighty":-8.145558,"marketCap":840151237},{"date":"2025-10-31","current":-15.563946,"twenty":-17.690689,"median":-12.292165,"eighty":-8.168128,"marketCap":815519652},{"date":"2025-11-07","current":-10.439663,"twenty":-17.665927,"median":-12.292165,"eighty":-8.196087,"marketCap":614718687},{"date":"2025-11-14","current":-14.07658,"twenty":-17.595178,"median":-12.325665,"eighty":-8.25011,"marketCap":828871278},{"date":"2025-11-21","current":-14.730193,"twenty":-17.553908,"median":-12.761733,"eighty":-8.286974,"marketCap":867357940},{"date":"2025-11-28","current":-16.218091,"twenty":-17.524554,"median":-12.861347,"eighty":-8.308212,"marketCap":954969853},{"date":"2025-12-05","current":-14.825843,"twenty":-17.466248,"median":-13.119398,"eighty":-8.337771,"marketCap":872990135},{"date":"2025-12-12","current":-13.01911,"twenty":-17.42774,"median":-13.221067,"eighty":-8.354198,"marketCap":766604240},{"date":"2025-12-19","current":-9.070865,"twenty":-17.407695,"median":-13.037789,"eighty":-8.414622,"marketCap":534119770},{"date":"2025-12-26","current":-9.108063,"twenty":-17.390007,"median":-12.866196,"eighty":-8.500376,"marketCap":536310068},{"date":"2026-01-02","current":-8.502276,"twenty":-17.333409,"median":-12.777948,"eighty":-8.502276,"marketCap":500639504},{"date":"2026-01-09","current":-8.098418,"twenty":-17.315721,"median":-12.328345,"eighty":-8.502276,"marketCap":476859127},{"date":"2026-01-16","current":-9.639455,"twenty":-17.280347,"median":-12.249123,"eighty":-8.498134,"marketCap":567600037},{"date":"2026-01-23","current":-11.302713,"twenty":-17.228465,"median":-12.093174,"eighty":-8.501448,"marketCap":665537640},{"date":"2026-01-30","current":-9.448154,"twenty":-17.210778,"median":-11.871572,"eighty":-8.502276,"marketCap":556335648},{"date":"2026-02-06","current":-7.42355,"twenty":-17.195449,"median":-11.633633,"eighty":-8.39709,"marketCap":437120866},{"date":"2026-02-09","current":-7.556398,"twenty":-17.191911,"median":-11.545952,"eighty":-8.358948,"marketCap":444943359}],"updateTime":1770752826130},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LENZ\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610260366","title":"Amplia Therapeutics Opens Two Sites for Pancreatic Cancer Trial Enrollment; Shares Rise 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610260366","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610260366?lang=en_us&edition=fundamental","pubTime":"2026-02-11 09:02","pubTimestamp":1770771722,"startTime":"0","endTime":"0","summary":"Amplia Therapeutics  said it opened two sites in the US, which will shortly start recruitment activities for its Amplicity trial, according to a Wednesday filing with the Australian bourse.The trial will evaluate the company's lead drug, narmafotinib, in advanced pancreatic cancer patients, the filing said.An additional three sites in the US will be initiated in the near future as recruitment continues, the filing added.Shares of the company rose past 4% in recent Wednesday trade.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","BK4007","BK4139","LENZ","BK4539","ATX.AU"],"gpt_icon":0},{"id":"2610629328","title":"Neural Therapeutics’ Hanf.com Stake Delivers 58% Revenue Surge and Positive Operating Income","url":"https://stock-news.laohu8.com/highlight/detail?id=2610629328","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610629328?lang=en_us&edition=fundamental","pubTime":"2026-02-10 22:35","pubTimestamp":1770734105,"startTime":"0","endTime":"0","summary":"The latest update is out from Neural Therapeutics Inc. ( ($TSE:NURL) ). Neural Therapeutics Inc. reported that its portfolio company CWE European H...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neural-therapeutics-hanf-com-stake-delivers-58-revenue-surge-and-positive-operating-income?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neural-therapeutics-hanf-com-stake-delivers-58-revenue-surge-and-positive-operating-income?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ"],"gpt_icon":0},{"id":"2610362583","title":"Wedbush Cuts Price Target on Aprea Therapeutics to $7 From $11, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2610362583","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610362583?lang=en_us&edition=fundamental","pubTime":"2026-02-10 21:43","pubTimestamp":1770730997,"startTime":"0","endTime":"0","summary":"Wedbush Cuts Price Target on Aprea Therapeutics to $7 From $11, Keeps Outperform Rating","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ"],"gpt_icon":0},{"id":"2610623727","title":"Defence Therapeutics Refines Accum ADC Strategy With New Scientific Advisory Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2610623727","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610623727?lang=en_us&edition=fundamental","pubTime":"2026-02-10 21:38","pubTimestamp":1770730720,"startTime":"0","endTime":"0","summary":"Defence Therapeutics ( ($TSE:DTC) ) has shared an announcement. Defence Therapeutics has convened a multidisciplinary Scientific Advisory Board to ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/defence-therapeutics-refines-accum-adc-strategy-with-new-scientific-advisory-board?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/defence-therapeutics-refines-accum-adc-strategy-with-new-scientific-advisory-board?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADC","BK4231","LENZ","BK4080","BK4139","BK4539","BK4007"],"gpt_icon":0},{"id":"2610623294","title":"Rapid Dose Therapeutics Enters Brazil’s Medical Cannabis Market With QuickStrip Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2610623294","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610623294?lang=en_us&edition=fundamental","pubTime":"2026-02-10 21:36","pubTimestamp":1770730589,"startTime":"0","endTime":"0","summary":"Rapid Dose Therapeutics Corp ( ($TSE:DOSE) ) has issued an update. Rapid Dose Therapeutics has launched its co-branded QuickStrip medical cannabis ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/rapid-dose-therapeutics-enters-brazils-medical-cannabis-market-with-quickstrip-launch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/rapid-dose-therapeutics-enters-brazils-medical-cannabis-market-with-quickstrip-launch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MSOS","LENZ","MSOX","BK4007","BK4539","BK4139"],"gpt_icon":0},{"id":"2610063640","title":"Cardiol Therapeutics’ ARCHER Phase II Myocarditis Data Published in ESC Heart Failure","url":"https://stock-news.laohu8.com/highlight/detail?id=2610063640","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610063640?lang=en_us&edition=fundamental","pubTime":"2026-02-10 20:58","pubTimestamp":1770728303,"startTime":"0","endTime":"0","summary":"Cardiol Therapeutics ( ($TSE:CRDL) ) just unveiled an update. Cardiol Therapeutics Inc., a late-stage life sciences company specializing in anti-in...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cardiol-therapeutics-archer-phase-ii-myocarditis-data-published-in-esc-heart-failure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cardiol-therapeutics-archer-phase-ii-myocarditis-data-published-in-esc-heart-failure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2610642580","title":"Sangamo Therapeutics Price Target Maintained With a $10.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2610642580","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610642580?lang=en_us&edition=fundamental","pubTime":"2026-02-10 20:01","pubTimestamp":1770724860,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SGMO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 10, 2026 07:01 ET (12:01 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ"],"gpt_icon":0},{"id":"2610893641","title":"Why Is Quince Therapeutics Stock Soaring Tuesday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2610893641","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610893641?lang=en_us&edition=fundamental","pubTime":"2026-02-10 18:58","pubTimestamp":1770721080,"startTime":"0","endTime":"0","summary":"Quince Therapeutics, Inc.  stock is up during Tuesday’s premarket session as the company has engaged LifeSci Capital to serve as its exclusive financial advisor.The penny stock is trading higher on a robust session volume of 29.84 million versus the average volume of 2.92 million, according to Benzinga Pro data.Currently, Quince Therapeutics is trading 89.6% below its 20-day simple moving average  and 91.2% below its 100-day SMA, indicating significant weakness in the short to medium term. Over the past 12 months, shares have decreased by 90.91%, and they are positioned closer to their 52-week lows than highs, reflecting ongoing challenges for the company.The RSI is at 22.15, indicating that the stock is in oversold territory, which could suggest a potential for a rebound if buying interest increases. Meanwhile, the MACD is below its signal line, reinforcing the bearish pressure on the stock.The combination of oversold RSI and bearish MACD suggests mixed momentum, indicating that while","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/02/10/Close-Up-Computer-Display-With-Red-And-G.jpeg?optimize=medium&dpr=2&auto=webp&width=630","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/02/10/Close-Up-Computer-Display-With-Red-And-G.jpeg?optimize=medium&dpr=2&auto=webp&width=630"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/trading-ideas/movers/26/02/50502899/why-is-quince-therapeutics-stock-soaring-tuesday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/02/50502899/why-is-quince-therapeutics-stock-soaring-tuesday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["LENZ","SMA","QNCX","BK4139","BK4007","BK4539","BK4217"],"gpt_icon":0},{"id":"2610871664","title":"Agomab Therapeutics Closes $200 Million IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2610871664","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610871664?lang=en_us&edition=fundamental","pubTime":"2026-02-10 06:28","pubTimestamp":1770676124,"startTime":"0","endTime":"0","summary":"Agomab Therapeutics  said late Monday it closed its initial public offering of 12.5 million American depository shares at a public offering price of $16 per ADS, raising about $200 million in gross proceeds before underwriting fees and expenses.The American depository shares started trading on the Nasdaq Global Select Market on Feb. 6.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","LENZ","BK4539","AGMB","BK4139"],"gpt_icon":0},{"id":"2610691326","title":"Marker Therapeutics Sets Date for 2026 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2610691326","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610691326?lang=en_us&edition=fundamental","pubTime":"2026-02-10 05:33","pubTimestamp":1770672829,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Marker Therapeutics ( ($MRKR) ). On February 9, 2026, Marker Therapeutics, Inc. announced that its Board of Dir...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/marker-therapeutics-sets-date-for-2026-annual-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/marker-therapeutics-sets-date-for-2026-annual-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","BK4007","LENZ"],"gpt_icon":0},{"id":"2610324658","title":"Lineage Cell Therapeutics Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2610324658","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610324658?lang=en_us&edition=fundamental","pubTime":"2026-02-09 20:50","pubTimestamp":1770641400,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LCTX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 09, 2026 07:50 ET (12:50 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LINE","LENZ"],"gpt_icon":0},{"id":"2610063011","title":"Context Therapeutics to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2610063011","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610063011?lang=en_us&edition=fundamental","pubTime":"2026-02-09 20:30","pubTimestamp":1770640200,"startTime":"0","endTime":"0","summary":"PHILADELPHIA, Feb.  09, 2026  (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/09/3234427/0/en/Context-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LENZ","BK4139","BK4539"],"gpt_icon":0},{"id":"2610637278","title":"Oruka Therapeutics to Participate in Multiple Upcoming Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2610637278","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610637278?lang=en_us&edition=fundamental","pubTime":"2026-02-09 20:00","pubTimestamp":1770638400,"startTime":"0","endTime":"0","summary":"MENLO PARK, Calif., Feb.  09, 2026  (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical-stage biotechnology company developing novel biologics designed to set a new stand","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/09/3234400/0/en/Oruka-Therapeutics-to-Participate-in-Multiple-Upcoming-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4007","BK4539","BK4139"],"gpt_icon":0},{"id":"2610634627","title":"Vistagen Therapeutics Securities Litigation: When Clinical Optimism Meets Disclosure Duty","url":"https://stock-news.laohu8.com/highlight/detail?id=2610634627","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610634627?lang=en_us&edition=fundamental","pubTime":"2026-02-09 19:12","pubTimestamp":1770635542,"startTime":"0","endTime":"0","summary":"Legal Context: Obligations at the Intersection of Science and Securities Law Federal securities law imposes clear obligations on public companies: ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/vistagen-therapeutics-securities-litigation-when-clinical-optimism-meets-disclosure-duty?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/vistagen-therapeutics-securities-litigation-when-clinical-optimism-meets-disclosure-duty?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","US7Y.BOND","US10Y.BOND","BK4539","BK4139","US5Y.BOND","TMF","US2Y.BOND","US30Y.BOND","US12M.BOND","US3Y.BOND","TLT","TLTW","US6M.BOND","BK4007"],"gpt_icon":0},{"id":"2610259680","title":"Stifel Nicolaus Reaffirms Their Hold Rating on HLS Therapeutics Inc (HLS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2610259680","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610259680?lang=en_us&edition=fundamental","pubTime":"2026-02-09 16:37","pubTimestamp":1770626228,"startTime":"0","endTime":"0","summary":"In a report released on February 6, Justin Keywood from Stifel Nicolaus maintained a Hold rating on HLS Therapeutics Inc, with a price target of C$...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-reaffirms-their-hold-rating-on-hls-therapeutics-inc-hls-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-reaffirms-their-hold-rating-on-hls-therapeutics-inc-hls-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","SF"],"gpt_icon":0},{"id":"2610697682","title":"Shield Therapeutics Wins Extra U.S. FDA Exclusivity for ACCRUFeR Pediatric Use","url":"https://stock-news.laohu8.com/highlight/detail?id=2610697682","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610697682?lang=en_us&edition=fundamental","pubTime":"2026-02-09 15:27","pubTimestamp":1770622058,"startTime":"0","endTime":"0","summary":"An update from Shield Therapeutics ( ($GB:STX) ) is now available. Shield Therapeutics has secured an additional three years of U.S. FDA data exclu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/shield-therapeutics-wins-extra-u-s-fda-exclusivity-for-accrufer-pediatric-use?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/shield-therapeutics-wins-extra-u-s-fda-exclusivity-for-accrufer-pediatric-use?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4007","BK4539","BK4139"],"gpt_icon":0},{"id":"2610950768","title":"Arovella Therapeutics Announces Departure of Director Gary Phillips","url":"https://stock-news.laohu8.com/highlight/detail?id=2610950768","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610950768?lang=en_us&edition=fundamental","pubTime":"2026-02-09 11:17","pubTimestamp":1770607044,"startTime":"0","endTime":"0","summary":"Arovella Therapeutics Limited ( ($AU:ALA) ) has shared an update. Arovella Therapeutics Limited has disclosed that director Gary Phillips ceased to...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/arovella-therapeutics-announces-departure-of-director-gary-phillips?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/arovella-therapeutics-announces-departure-of-director-gary-phillips?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","BK4539","BK4007"],"gpt_icon":0},{"id":"2610502034","title":"PYC Therapeutics Opens Retail Entitlement Offer to Fund RNA Therapy Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2610502034","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610502034?lang=en_us&edition=fundamental","pubTime":"2026-02-09 10:42","pubTimestamp":1770604944,"startTime":"0","endTime":"0","summary":"PYC Therapeutics Limited ( ($AU:PYC) ) just unveiled an update. PYC Therapeutics has commenced the retail component of its previously announced 3-f...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pyc-therapeutics-opens-retail-entitlement-offer-to-fund-rna-therapy-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pyc-therapeutics-opens-retail-entitlement-offer-to-fund-rna-therapy-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RNA","BK4539","IE0009354923.USD","LENZ","BK4139","BK4505","BK4007","BK4585","BK4588"],"gpt_icon":0},{"id":"2610916505","title":"Arovella Therapeutics Interim Chair Retires; Shares Up 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610916505","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610916505?lang=en_us&edition=fundamental","pubTime":"2026-02-09 07:58","pubTimestamp":1770595091,"startTime":"0","endTime":"0","summary":"Arovella Therapeutics  said that interim Chair Elizabeth Stoner has retired, effective Monday, according to a same-day Australian bourse filing.The company will provide updates regarding the appointment of a new chair following the completion of a skills review, the filing added.The company's shares rose 4% in recent Monday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","BK7096","BK4539","BK4139","ALA.AU","BK4007"],"gpt_icon":0},{"id":"2610577774","title":"Assessing CARsgen Therapeutics Holdings’ Valuation After 2025 Earnings Guidance Points To Smaller Net Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2610577774","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610577774?lang=en_us&edition=fundamental","pubTime":"2026-02-09 01:11","pubTimestamp":1770570666,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics Holdings (SEHK:2171) issued preliminary 2025 earnings guidance indicating a sharp year on year reduction in net loss, driven by commercial activity, lower research costs, and foreign exchange effects.\nSee our latest analysis for CARsgen Therapeutics Holdings.\nCARsgen Therapeutics Holdings’ latest guidance lands after a volatile stretch, with a 6.32% 1 day share price return to HK$14.13 following recent weakness, including a 13.74% 30 day share price decline. The 1 year...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2171/carsgen-therapeutics-holdings-shares/news/assessing-carsgen-therapeutics-holdings-valuation-after-2025","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2171/carsgen-therapeutics-holdings-shares/news/assessing-carsgen-therapeutics-holdings-valuation-after-2025","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LENZ","PCOM"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}